Daio Paper published its results for the six months ended September 30, 2026 on November 13. In its domestic product-category discussion, the company reported year-on-year increases in both sales volume and sales value for healthcare.
The issuer cited adult-diaper price revisions, stronger sales of higher-value overnight pants and pads, and additional adoption of university–industry products through hospitals and care facilities. This describes business activity during the period; it is not a new product launch announcement.
The broader Home & Personal Care segment, including domestic and overseas operations, recorded revenue of JPY 147.543 billion, up 4.2%, and segment profit of JPY 4.197 billion, up 71.5%. Daio also attributed profit growth substantially to restructuring overseas. Prior-period comparisons were restated to reflect changes in its reporting segments.
These segment figures include other businesses, such as tissue, baby care and feminine care. They are not adult-diaper-only results. The release does not provide standalone adult-diaper revenue, profit, growth percentages or the number of adopting institutions. Product aims concerning overnight caregiving should not be read as independently demonstrated clinical outcomes.